Journal of Cataract & Refractive Surgery
Volume 33, Issue 11 , Pages 1925-1929 , November 2007

Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery: Prospective randomized double-masked clinical trial

,Accepted 3 July 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 No author has a financial or proprietary interest in any material or method mentioned.

 Allergan and Alcon supplied the clinic with samples of their respective products and provided postoperative surgical packs for all patients.

 The staff members and ophthalmic technicians at the Westfield Eye Center and nurses at the American Surgery Center provided assistance throughout the study period.

PII: S0886-3350(07)01385-5

doi: 10.1016/j.jcrs.2007.07.017

Journal of Cataract & Refractive Surgery
Volume 33, Issue 11 , Pages 1925-1929 , November 2007

Article Tools

* Image Usage & Resolution